Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Optical correction of aphakia refers to various interventions to restore vision in patients lacking the natural lens of the eye, most commonly due to surgical removal (such as cataract extraction), trauma, or congenital absence[1][3][4]. Correction methods include thick high-plus glasses (rarely used, especially in children due to poor optics and cosmetic/social drawbacks), specialized contact lenses (rigid gas-permeable, silicone elastomer, hydrogel), and intraocular lens (IOL) implantation[4][5][6][7][8]. IOL implantation is often preferred for permanent correction in adults, while contact lenses are frequently used in infants and children because of developmental concerns and surgical limitations[6][7]. Each intervention has distinct optical and safety profiles, and patient selection and ongoing management are critical for effective rehabilitation and minimizing complications[7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Optical correction of aphakia.